Lupin Wins FDA Approval for Pitolisant Tablets
Mumbai, India and Naples, Italy, August 17, 2026 Lupin Limited, a global pharmaceutical company, announced that it has received...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mumbai, India and Naples, Italy, August 17, 2026 Lupin Limited, a global pharmaceutical company, announced that it has received...
Emeryville, California, August 17, 2026 OmniAb, Inc. has announced a new global collaboration and license agreement with Eli Lilly...
